Forteo (Eli Lilly and Company)
Welcome to the PulseAid listing for the Forteo drug offered from Eli Lilly and Company. This Parathyroid Hormone [Chemical/Ingredient],Parathyroid Hormone Analog [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Eli Lilly and Company |
| NON-PROPRIETARY NAME: | Teriparatide |
| SUBSTANCE NAME: | TERIPARATIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Parathyroid Hormone [Chemical/Ingredient],Parathyroid Hormone Analog [EPC] |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2002-11-26 |
| END MARKETING DATE: | 0000-00-00 |
Forteo HUMAN PRESCRIPTION DRUG Details:
| Item Description | Forteo from Eli Lilly and Company |
| LABELER NAME: | Eli Lilly and Company |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 250(ug/mL) |
| START MARKETING DATE: | 2002-11-26 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0002-8400_4d0a0023-d348-41dd-a689-43971e41d26f |
| PRODUCT NDC: | 0002-8400 |
| APPLICATION NUMBER: | NDA021318 |
Other TERIPARATIDE Pharmaceutical Manufacturers / Labelers:
